RAC1 and neoplasm: RAC1 activating mutations alone are insufficient to initiate carcinogenesis in skin, colorectal and lung cancer, but cooperation with BRAF or KRAS mutations results in enhanced proliferation and accelerated tumour growth [9,87,101,104,121].